Novartis is one of the industry’s biggest investors in research. Our success depends on the creativity and performance of our associates. Novartis operates in 140 countries around the world. Novartis Biologics is dedicated to delivering targeted biological therapies that can improve the live of patients around the world. Our collaborative efforts differentiate us from other healthcare companies.
We believe our portfolio best meets the varied and often complex needs of patients and societies. Novartis is positioned to lead in innovation, partner with others and offer solutions to patients across a broad healthcare spectrum. In addition, a diverse portfolio reduces financial risk, bringing greater value to those who invest in our company.
Novartis has been transformed since its creation in 1996 - when only 45% of net sales came from healthcare - into a leader focused on fast-growing areas of healthcare.
Novartis want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.
We also want to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest ideas and work in our company.